Sofinnova Management X-A, L.L.C., 10% Owner, Director at Vera Therapeutics, Inc. (VERA), bought 285,714 shares at $7.00 ($2.0M) on 2023-02-06, disclosed to the SEC on 2023-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.